Voglow GM 1mg/500mg/0.2mg Tablet PR
By Voglow GM
Rx
10 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Primus Remedies Pvt Ltd
Primus Remedies Pvt Ltd, C-16, Ankur Cooperative Society, Thakurli Estate, Dombivili, Mumbai-421202.

Expires on or after
February, 2027

liver
When taking Voglow GM 1mg/500mg/0.2mg Tablet PR, be cautious if you have liver disease. It may be necessary to adjust the dose, so it's important to consult your doctor before using this medication. Typically, for patients with mild to moderate liver disease, Voglow GM 1mg/500mg/0.2mg Tablet PR is initially administered at a low dose. However, it is not advisable for individuals with severe liver disease to use this medication without proper medical guidance.

kidney
Voglow GM 1mg/500mg/0.2mg Tablet PR may be unsafe for patients with kidney disease. It is advised to avoid using this medication. Please consult your doctor before using Voglow GM 1mg/500mg/0.2mg Tablet PR, especially if you have severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Voglow GM 1mg/500mg/0.2mg Tablet PR. Please avoid consuming alcohol to prevent any potential risks or complications.

driving
When your blood sugar levels are too low or too high, it can affect your ability to drive safely. If you experience these symptoms, avoid driving while taking Voglow GM 1mg/500mg/0.2mg Tablet PR.

pregnancy
Voglow GM 1mg/500mg/0.2mg Tablet PR may be unsafe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
It is not recommended to use Voglow GM 1mg/500mg/0.2mg Tablet PR while breastfeeding as it may pass into breastmilk and be harmful to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹119
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024